Therapeutics: Histone deacetylase (HDAC); runt-related transcription factor 3 (RUNX3)

Cancer

INDICATION: Cancer; solid tumors

In vitro and rodent studies suggest HDAC inhibitors that activate the tumor suppressor RUNX3 could

Read the full 180 word article

How to gain access

Continue reading with a
two-week free trial.